A blog about chemistry, drug development, science, and technology
Not much new here except that Sanofi-aventis has resubmitted their NDA for Acomplia (rimonabant) on Oct 26 and the FDA has accepted it.
PharmaLive: Rimonabant Update in the United States :
The goal is to have a decision by Apr 26, 2007 according to the user fee goals.
Nothing else new to really to note.
Technorati Tags: Acomplia, Rimonabant, Sanofi-Aventis
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.317 seconds